Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.33 |
| ▸ | EGLN2 | Q96KS0 | 2/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.32 |
| ▸ | BRD1 | O95696 | 1/20 | 0.32 |
| ▸ | TAF1 | P21675 | 1/20 | 0.32 |
| ▸ | BRPF1 | P55201 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21710704 | 0.89 | MAPK1 (0.36) | CA1CA2ALDH1A1CYP1A2HPGD | |
| SCHEMBL21710731 | 0.87 | ENPP3 (0.37) | CA1CA2ALDH1A1MAPK1MAPK9 | |
| SCHEMBL22679479 | 0.87 | CYP1A2 (0.40) | ALDH1A1CYP1A2HPGDCYP3A4MAPT | |
| SCHEMBL21710649 | 0.87 | PTGER4 (0.39) | ALDH1A1HPGDKDM4EMEN1MAPT | |
| SCHEMBL21717834 | 0.86 | CA1 (0.40) | CA1CA2MEN1KMT2APTGER4 | |
| SCHEMBL21710702 | 0.86 | CA1 (0.37) | CA1CA2ALDH1A1CYP1A2HPGD | |
| SCHEMBL21710487 | 0.85 | CA1 (0.39) | CA1CA2ALDH1A1CYP1A2HPGD | |
| SCHEMBL21710589 | 0.83 | CA1 (0.47) | CA1CA2ALDH1A1CYP1A2HPGD | |
| SCHEMBL22679283 | 0.83 | PTGER4 (0.35) | CA1CA2ALDH1A1CYP1A2HPGD | |
| SCHEMBL21717865 | 0.81 | ENPP3 (0.35) | CA1CA2ALDH1A1CYP1A2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11723272-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-11723272-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20210005825-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2021-01-07 | — | — | US | disclosed |
| US-20210005826-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO., LTD. (JP) | 2021-01-07 | — | — | US | disclosed |
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | LEF1, L1CAM, ESR2 | CA1 2666/4885CA2 1903/4885ALDH1A1 153/4885 |
| US-20210005825-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | OR51E2, CD99, CTNND1 | CA1 2333/4885CA2 2351/4885ALDH1A1 37/4885 |
| US-20210005826-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS | EML4, EBPL, LEF1 | CA1 2980/4885CA2 3016/4885ALDH1A1 189/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.